نتائج البحث

(6R,7R)-7-([(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino)-3-[(5-methyltetrazol-2-yl)methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2

| IUPAC_name = 1-[2-[3-(2,2-diphenylethyl)-1,2,4-oxadiazol-5-yl]ethyl]piperidine | C=23 | H=27 | N=3 | O=1

...17(19(23)24)18(22)21(16-12-8-5-9-13-16)20-15-10-6-4-7-11-15/h4-13,17,20H,2-3,14H2,1H3,(H,23,24) ...17(19(23)24)18(22)21(16-12-8-5-9-13-16)20-15-10-6-4-7-11-15/h4-13,17,20H,2-3,14H2,1H3,(H,23,24)

...2-Amino-1,3-thiazol-4-yl)- 2-[[(3S)-2,2-dimethyl-4-oxo-1- sulfooxyazetidin-3-yl]amino]-2- oxoethylidene]amino]oxyacetic acid

|IUPACName=(''RS'')-''N''-[2-([3-(2-cyanophenoxy)-2-hydroxypropyl]amino)ethyl]-2-(4-hydroxyphenyl)acetamide | Formula=C₂₀H₂₃N₃O₄

...1,3-thiazol-4-yl)-2-[[(2S,3S)-2-(carbamoyloxymethyl)-4-oxo-1-sulfoazetidin-3-yl]amino]-2-oxoethylidene]amino]oxyacetic acid

(6R,7R)-7-{[2-(3,5-dichloro-4-oxopyridin-1-yl) acetyl]amino}-3-[(5-methyl-1,3,4-thiadiazol-2-yl)

...e = (2''S'')-2-[(phenylmethylamino)methyl]-2,3,7,9-tetrahydro-[1,4]dioxino[3,2-e]indol-8-one | N=2 | O=3

| IUPAC_name = 3-[5-(4-Chlorophenyl)-1-(4-methoxyphenyl)pyrazol-3-yl]-''N''-hydroxy-''N''-methylpropanamide | C=20 | H=20 | Cl=1 | N=3 | O=3

...'S'')-2-benzhydryl-''N''-[(5-isopropyl-2-methoxy-phenyl)methyl]quinuclidin-3-amine

| InChI = 1/C6H13NO2/c1-4(2)3-5(7)6(8)9/h4-5H,3,7H2,1-2H3,(H,8,9)/t5-/m0/s1 | StdInChI = 1S/C6H13NO2/c1-4(2)3-5(7)6(8)9/h4-5H,3,7H2,1-2H3,(H,8,9)/t5-/m0/s1

| IUPAC_name = 1-[4-(2-methoxyphenyl)piperazin-1-yl]-3-(1-naphthyloxy)propan-2-ol | C=24 | H=28 | N=2 | O=3

...)-3,3-dimethyl-7-oxo-6-[(2-phenyl-2-sulfoacetyl)amino]-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid

| Formula = NaBO₃ <!-- e.g. Na₂CO₃ --> | Density = 1.73 غ/سم³ <!-- سائل.. غ/مل، صلب.. غ/سم³ -->

| CAS_number = 31431-43-3 | InChI = 1/C13H13N3O3/c1-19-13(18)16-12-14-9-5-4-8(6-10(9)15-12)11(17)7-2-3-7/h4-7H,2-3H2,1H3,(H2,14,15,16,18)

| الاسم حسب IUPAC|| 3-(1-methyl-7-oxo-3-propyl-4H-pyrazolo[4,3-d]pyrimidin-5-yl)-N-[2-(1-methylpyrrolidin-2-yl)ethyl]-4-propoxybenzenesulf

|IUPACName=3-[(1-benzylcycloheptyl)oxy]-''N,N''-dimethylpropan-1-amine ...O/c1-20(2)15-10-16-21-19(13-8-3-4-9-14-19)17-18-11-6-5-7-12-18/h5-7,11-12H,3-4,8-10,13-17H2,1-2H3

6-Chloro-4-hydroxy-2-methyl-N-2-pyridyl-2H-thieno[2,3-e][1,2]-thiazine-3-carboxamide 1,1-dioxide. ...البلازما بعد ما يقارب 1 إلى 2 ساعة، الحد الأقصى للتركيز من 1.5 إلى حوالي 2.3 ساعة ويمكن أن تقلل من المنطقة تحت المنحنى

| IUPAC_name = (''RS'')-2-methoxy-''N''-methyl-2-[3-(trifluoromethyl)phenyl]ethanamine | C=11 | H=14 | F=3 | N=1 | O=1

*البالغين: 2.5-5 ملغ 3 مرات/يوم. *الأطفال من 6-12 سنة: 1.25 ملغ 3 مرات/يوم.